Company profile

SystImmune Tech Stack

Clinical-stage oncology biologics: bispecific, trispecific antibodies and ADCs

Biotechnology Research Bothell, WA 51–200 employees Founded 2014 Privately Held

SystImmune develops multi-specific antibodies and ADCs for solid tumors, pairing a classic clinical-pharmacology stack (SAS, CDISC, NONMEM, WinNonlin, Spotfire) with an AI protein-design toolkit (AlphaFold, ProteinMPNN, GROMACS, Llama, LangChain, Milvus, Ray). Senior- and director-heavy research hiring, plus a Chief Commercial Officer search and NDA/BLA submission work, points to a push from clinical stage toward commercialization.

Tech Stack 42 technologies

Core StackSAS Python LangChain MariaDB AWS NetSuite Hugging Face Ollama Palo Alto Networks Cisco VMware CDISC Spotfire IronPython NONMEM WinNonlin Leica HPLC Llama ProteinMPNN Milvus Dask Ray MPI LIMS AlphaFold GROMACS UPLC Concur GraphPad Prism+11 more

What SystImmune Is BuildingChallenges and projects from their job posts

◆Challenges

Transitioning from clinical-stage to commercial-stage
Patient recruitment barriers in clinical trials
Controlling clinical trial costs and budget variance
Managing safety data from multiple sources
Supply shortage risk across multi-geography supply chains
Pricing competitiveness

▲Active Projects

NDA/BLA regulatory submissions
Clinical trial implementation and study planning
CDx IHC development across oncology programs
Cell-free expression platform
Display-based protein engineering campaigns
Medical data review and monitoring plan

Hiring Activity

Accelerating45 roles · 15 in 30d

Department

Research

Data

Healthcare

Finance

Clinical

Legal

Ops

Seniority

Senior

Director

Mid

Junior

Intern

Principal

Notable leadership hires: Analytical Director, Chief Commercial Officer

Companies like SystImmune

100+ Biotechnology Research companies running SAS and Python

See the full list

About SystImmune

SystImmune is a privately held biopharmaceutical company founded in 2014 and headquartered in Bothell, WA. It develops antibody-based cancer therapies, including bispecific and trispecific antibodies and antibody-drug conjugates, designed to act on the solid tumor microenvironment by attacking tumors directly or engaging the immune system. The company employs 51–200 people and hires in the United States. Its work spans discovery research, protein engineering, analytical development and clinical trial operations, supported by business systems such as NetSuite and Concur.

HeadquartersBothell, WA

Company Size51–200 employees

Founded2014

Hiring MarketsUnited States

Frequently Asked Questions

What tech stack does SystImmune use?

SystImmune uses SAS, CDISC, Spotfire, NONMEM and WinNonlin for clinical and PK analysis, AlphaFold, ProteinMPNN and GROMACS for protein design, plus Python, Ray, Dask, AWS, LIMS and NetSuite.

Is SystImmune hiring?

Yes. Hiring is accelerating and centers on research roles, with data, clinical and healthcare positions plus leadership searches including an Analytical Director and Chief Commercial Officer, all in the United States.

What is SystImmune working on?

Current work includes clinical trial implementation, NDA/BLA regulatory submissions, companion diagnostic IHC development across oncology programs, a cell-free expression platform and display-based protein engineering.

Similar Companies in Biotechnology Research

Other companies in the same industry, closest in size

Structure Therapeutics

Biotechnology Research

Kymera Therapeutics

Biotechnology Research

Capricor Therapeutics, Inc.

Biotechnology Research

Kodiak Sciences

Biotechnology Research

How this profile is built

SystImmune's technology stack, projects, and hiring signals are inferred from public hiring and company data — career pages, public listings, and company web presence — then clustered and de-duplicated. Figures are estimates that refresh over time. Read our full methodology →

This is not an official vendor or customer list. It is a technology-adoption signal inferred from public data, intended for B2B research.